MK-0777 for the treatment of cognitive impairments in patients with schizophrenia.
Phase of Trial: Phase II
Latest Information Update: 01 Mar 2011
At a glance
- Drugs MK 0777 (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Acronyms TURNS
- 15 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Aug 2007 New trial record.